157 related articles for article (PubMed ID: 38438773)
21. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström TJ; Bäckdahl M; Larsson C
Endocr Relat Cancer; 2008 Jun; 15(2):609-21. PubMed ID: 18509008
[TBL] [Abstract][Full Text] [Related]
22. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
Purkait S; Jha P; Sharma MC; Suri V; Sharma M; Kale SS; Sarkar C
Neuropathology; 2013 Aug; 33(4):405-12. PubMed ID: 23311918
[TBL] [Abstract][Full Text] [Related]
23. 1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2/M arrest and apoptosis of human glioblastoma cells in vitro.
Liu SS; Wang YF; Ma LS; Zheng BB; Li L; Xie WD; Li X
Acta Pharmacol Sin; 2013 Feb; 34(2):271-81. PubMed ID: 23160341
[TBL] [Abstract][Full Text] [Related]
24. Modified CDKN2B (p15) and CDKN2A (p16) DNA methylation profiles in urban pesticide applicators.
Herrera-Moreno JF; Medina-Díaz IM; Bernal-Hernández YY; Ramos KS; Alvarado-Cruz I; Quintanilla-Vega B; González-Arias CA; Barrón-Vivanco BS; Rojas-García AE
Environ Sci Pollut Res Int; 2019 May; 26(15):15124-15135. PubMed ID: 30924039
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
26. Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma.
Mohseny AB; Tieken C; van der Velden PA; Szuhai K; de Andrea C; Hogendoorn PC; Cleton-Jansen AM
Genes Chromosomes Cancer; 2010 Dec; 49(12):1095-103. PubMed ID: 20737480
[TBL] [Abstract][Full Text] [Related]
27. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis.
Chen H; Deng J; Hou TW; Shan YQ
J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
29. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of CDKN2A methylation, mRNA, and p16(INK4a) protein expression in children and adolescents with Burkitt lymphoma: biological and clinical implications.
Robaina MC; Faccion RS; Arruda VO; de Rezende LM; Vasconcelos GM; Apa AG; Bacchi CE; Klumb CE
Leuk Res; 2015 Feb; 39(2):248-56. PubMed ID: 25542698
[TBL] [Abstract][Full Text] [Related]
31. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma.
Indovina P; Acquaviva A; De Falco G; Rizzo V; Onnis A; Luzzi A; Giorgi F; Hadjistilianou T; Toti P; Tomei V; Pentimalli F; Carugi A; Giordano A
J Cell Physiol; 2010 Apr; 223(1):143-50. PubMed ID: 20039270
[TBL] [Abstract][Full Text] [Related]
32. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas.
Alves MK; Lima VP; Ferrasi AC; Rodrigues MA; De Moura Campos Pardini MI; Rabenhorst SH
APMIS; 2010 Apr; 118(4):297-307. PubMed ID: 20402675
[TBL] [Abstract][Full Text] [Related]
33. p15 promoter methylation - a novel prognostic marker in glioblastoma patients.
Wemmert S; Bettscheider M; Alt S; Ketter R; Kammers K; Feiden W; Steudel WI; Rahnenführer J; Urbschat S
Int J Oncol; 2009 Jun; 34(6):1743-8. PubMed ID: 19424593
[TBL] [Abstract][Full Text] [Related]
34. [Inactivation of CDKN2A gene (p16) in gallbladder carcinoma].
Roa JC; Vo Q; Araya JC; Villaseca M; Guzmán P; Ibacache GS; de Aretxabala X; Roa I
Rev Med Chil; 2004 Nov; 132(11):1369-76. PubMed ID: 15693199
[TBL] [Abstract][Full Text] [Related]
35. Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis.
Herzog CR; Noh S; Lantry LE; Guan KL; You M
Mol Carcinog; 1999 Jun; 25(2):92-8. PubMed ID: 10365910
[TBL] [Abstract][Full Text] [Related]
36. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
[TBL] [Abstract][Full Text] [Related]
37. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.
Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R
J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional regulation of
Rodríguez S; Bermúdez LG; González D; Bernal C; Cañas A; Morales-Ruíz T; Henríquez B; Rojas A
Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36169180
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
40. Expression of DNAJB9 and some other genes is more sensitive to SWCNTs in normal human astrocytes than glioblastoma cells.
Minchenko DO; Rudnytska OV; Khita OO; Kulish YV; Viletska YM; Halkin OV; Danilovskyi SV; Ratushna OO; Minchenko OH
Endocr Regul; 2023 Jan; 57(1):162-172. PubMed ID: 37561833
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
